OP
Healthcare & Life Sciences
Onchilles Pharma
United Stateswww.onchillespharma.com/
Onchilles Pharma is a Healthcare & Life Sciences startup based in the United States, most recent round Series A, 1 tracked investor.
Activeseries-a
series-a
Stage
1
Investors
About Onchilles Pharma
Based in the United States, Onchilles Pharma is a startup. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Onchilles Pharma develops cancer-selective cytotoxic therapeutics that target the ELANE pathway to selectively kill cancer cells while preserving and activating the immune system. Their lead product, N17350 (NEU-001), is in Phase 1/2 clinical trials for advanced solid tumors.
Explore Onchilles Pharma's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.